Core Laboratory
The primary role of the Core Team is to deliver GCP- and GLP-compliant CTIMP and non-CTIMP studies. The team also manages biobanking activities in accordance with UK and relevant EU regulatory requirements, including HTA. At any one time, the team typically supports 3–7 main studies, alongside approximately 10 associated sub-studies.
The team supports a range of clinical and translational research activities. These include collaboration with clinical staff and research partners across the UK and Europe, the processing and long-term storage of human-derived samples, data generation and analysis, SOP development and optimisation, as well as the management and quality control of data, samples and laboratory equipment. These activities have contributed to publications in leading scientific journals, including The Lancet (2021, 2023) and Nature journals (2018, 2025).
The Core Team comprises a diverse group of scientific and technical staff. The team performs histological, immunohistochemical and molecular analyses of human-derived samples across multiple research projects. The clinical studies delivered by the team contribute to the scientific outputs and successful funding of the department, while supporting high-quality research within Experimental Medicine and Rheumatology. The team also provides a specialist technical service for the analysis of RNA, DNA and protein samples using state-of-the-art NanoString technology. Our nCounter SPRINT service can be requested through the iLab platform (https://qmul.corefacilities.org).